Psoriasis vs Eczema: How to Tell the Difference

Research-informed explainer — last updated April 12, 2026

Psoriasis and eczema both cause red, inflamed, itchy skin — but they're different diseases with different underlying causes, different triggers, and treatments that don't always overlap. Getting the diagnosis right matters because using the wrong treatment can fail to help or, in some cases, make things worse.

This explainer covers how to tell psoriasis from eczema, what the treatment approach looks like for each, and where newer biologics have changed the picture. It draws on published practice guidelines from dermatologists at UCSF and the University of Pennsylvania, including work on the AAD's guidelines for atopic dermatitis management.

What's the difference?

The short version: eczema is driven by a disrupted skin barrier and an overactive immune response to allergens and irritants; psoriasis is an autoimmune disease where the immune system attacks healthy skin cells, causing them to multiply too fast.

Eczema (atopic dermatitis, or AD) most often starts in childhood. The skin barrier is defective — a mutation in the filaggrin gene is one well-established contributor — which allows allergens and irritants to penetrate, triggering immune inflammation. Eczema tends to show up in the creases of the elbows and knees, on the neck, and around the wrists and ankles. The skin is usually dry, weepy when flared, and intensely itchy. It's closely associated with allergic conditions like asthma and hay fever.

Psoriasis is less likely to start in childhood (though it can) and more commonly appears in early adulthood or midlife. Immune cells called T-cells mistakenly attack skin cells, speeding up the skin cell turnover cycle from about a month to just a few days. Those excess cells pile up as thick, silvery-white scales over red plaques. Common locations include the elbows, knees, scalp, and lower back. Psoriasis is associated with systemic conditions — psoriatic arthritis develops in roughly 30% of psoriasis patients, and there are documented links to cardiovascular disease and metabolic syndrome.

At a glance

How eczema is treated

The AAD's practice guidelines, developed in part by dermatologists at UCSF, lay out a step-by-step treatment framework based on disease severity [1][2][3].

For mild-to-moderate eczema:

• Skin barrier restoration is the starting point — fragrance-free moisturizers applied frequently, gentle cleansers, and avoiding known triggers
• Topical corticosteroids are the standard short-term treatment for active flares, applied to inflamed areas until they settle
• Topical calcineurin inhibitors (tacrolimus, pimecrolimus) are steroid-free alternatives for sensitive areas like the face and neck, or for patients who can't use steroids long-term

For moderate-to-severe eczema that doesn't respond to topical therapy:

• Phototherapy (controlled UV light exposure) is an option for widespread disease
• Systemic immunosuppressants — cyclosporine, methotrexate, azathioprine, mycophenolate — are used for severe refractory cases, with the understanding that they require monitoring for side effects [3]
• Dupilumab (Dupixent), a biologic targeting the IL-4/IL-13 inflammatory pathway, was the first biologic approved specifically for moderate-to-severe AD and has changed the picture for adults who weren't responding to older systemic treatments

How psoriasis is treated

Psoriasis treatment follows a similar pyramid: mild-to-moderate disease is managed topically; widespread or severe disease often requires systemic treatment.

For limited psoriasis:

• Topical corticosteroids are first-line for most patients, applied to plaques
• Vitamin D analogues (calcipotriene) reduce skin cell turnover; they're often combined with topical steroids
• Coal tar and salicylic acid remain options for scalp psoriasis and thickened plaques

For moderate-to-severe psoriasis:

• Phototherapy (narrowband UVB or PUVA) can be highly effective for widespread disease
• Traditional systemic agents include methotrexate, cyclosporine, and acitretin (a retinoid)
• Biologics have transformed treatment for moderate-to-severe psoriasis: TNF inhibitors (adalimumab, etanercept), IL-17 inhibitors (secukinumab, ixekizumab), and IL-23 inhibitors (guselkumab, risankizumab) now offer sustained clearance that wasn't achievable with older medications

How do doctors tell them apart?

A trained dermatologist can usually tell psoriasis from eczema by examination alone. The distribution, texture, and appearance differ enough that clinical diagnosis is generally straightforward. When there's genuine uncertainty, a skin biopsy can resolve it — the microscopic appearance of eczema and psoriasis is distinctly different.

The skin diseases that are harder to distinguish aren't usually eczema vs. psoriasis — they're subtypes within each category, or overlap conditions like contact dermatitis (which can mimic eczema) or inverse psoriasis (which can look less like classic psoriasis and more like a rash). Autoimmune skin diseases like cutaneous lupus also require differentiation; dermatology researchers have developed validated scoring systems like the CLASI to track cutaneous lupus activity and distinguish it from other inflammatory skin conditions [4].

UV exposure and skin conditions

The relationship with UV light is actually opposite between the two diseases: sunlight typically worsens eczema, because heat, sweat, and UV exposure can trigger flares. Psoriasis, by contrast, often improves with sun exposure — UV light slows the abnormal skin cell proliferation that drives psoriatic plaques, which is why phototherapy works for psoriasis. Research on UV exposure and skin effects has established that while controlled phototherapy is therapeutic, unprotected cumulative UV exposure raises melanoma and non-melanoma skin cancer risk over time [8].

This UV difference is one reason psoriasis patients are sometimes advised moderate sun exposure while eczema patients are generally advised to protect themselves from it.

Questions to ask your doctor

• How do you know whether I have psoriasis or eczema? Is a biopsy needed, or is the clinical picture clear?
• Should I keep a diary of flares to identify my personal triggers?
• If topical steroids haven't been working, what's the next step for my disease severity?
• Am I a candidate for a biologic, and if so, which one is best suited to my pattern of disease?
• If I have psoriasis, should I be screened for psoriatic arthritis even if my joints feel fine?
• What moisturizers and skin care routine do you recommend specifically for my skin type and condition?

The bottom line

Psoriasis and eczema both cause inflamed, itchy skin, but they're caused by different immune mechanisms and managed with overlapping but distinct treatment approaches. Eczema centers on barrier repair and anti-inflammatory control; psoriasis centers on slowing immune-driven skin cell turnover. The appearance, location, and associated conditions differ enough that an experienced dermatologist can usually distinguish them quickly — and getting that diagnosis right is the first step toward treatment that actually works.

If over-the-counter approaches haven't cleared your skin after a few weeks, a dermatologist visit is worth it. Both conditions are treatable, and for moderate-to-severe cases, newer biologics have raised the ceiling on what "treated" can mean.